title: A comprehensive review of suburethral sling procedure complications.
abstract: The study objective was to review the existing literature regarding complications of anti-incontinence sling procedures. PubMed listings using keywords related to slings and associated complications with no date or language restrictions through May 2007 and the Manufacturer and User Facility Device Experience Database were searched for specific device- and procedure-related complications. Where no information was available, published abstracts were cited. Published reports of complications for all types of anti-incontinence sling procedures are analyzed and reported. Sling-related complications are multiple but can be summarized from studies on 13737 cumulative patients as involving: voiding dysfunction (8 studies, 881 patients, 16.3% average overall incidence [OI]); detrusor overactivity (20 studies, 1950 patients, 15.4% OI); urinary retention (14 studies, 943 patients, 14.2% OI); erosion/extrusion (19 studies, 2197 patients, 6.03% OI); impact on quality of life-dyspareunia (2 studies, 175 patients, 4.3% OI); infections-most often urinary tract infections but severe infections such as abscess are reported (19 studies, 1487 patients, 5.5% OI); hematoma-most often pelvic or vaginal (4 studies, 3691 patients, 2% OI); pain (6 studies, 597 patients, 7.3% OI); abdominal and pelvic organ injury-bladder, urethra, vagina, and intestines (10 studies, 1816 patients, 3.3% OI); systemic complications-deep vein thrombosis, sepsis (case reports); and death (case reports). Cure rates for all slings are as follows: subjective (16 studies, 1541 patients, 95% OI, range 63%-99%), objective (15 studies, 1203 patients, 82% OI, range 51%-97%), and failure (8 studies, 599 patients, 11.5% OI, range 4%-37%). It is likely that sling-related complications are under-reported in the published medical literature and in the Manufacturer and User Facility Device Experience Database. This review reports on the incidence of known complications for all types of slings. Some complications are common to all sling techniques; however, with development of minimally invasive slings, device-related complications are reported and compared.
authors.affiliation: Center for Advanced Pelvic Surgery, Centralia, Illinois 62801, USA. ejs222@aol.com
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Stanford
authors.forename: Marie Fidela R
authors.initials: MF
authors.lastname: Paraiso
mesh_terms: D006406:Hematoma / Q000453:epidemiology; D006801:Humans; D011183:Postoperative Complications / Q000453:epidemiology; D011474:Prosthesis Design; D011788:Quality of Life; D012008:Recurrence; D053825:Suburethral Slings / Q000009:adverse effects*; D014521:Urethra / Q000293:injuries; D001743:Urinary Bladder / Q000293:injuries; D014546:Urinary Catheterization; D014549:Urinary Incontinence / Q000453:epidemiology; D016055:Urinary Retention / Q000453:epidemiology